BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8454107)

  • 1. Benfluorex normalizes hyperglycemia and reverses hepatic insulin resistance in STZ-induced diabetic rats.
    Serradas P; Blondel O; Bailbe D; Portha B
    Diabetes; 1993 Apr; 42(4):564-70. PubMed ID: 8454107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of benfluorex on insulin secretion and insulin action in streptozotocin-diabetic rats.
    Portha B; Serradas P; Bailbé D; Blondel O; Picarel F
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():57S-63S. PubMed ID: 8299491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. d-Fenfluramine improves hepatic insulin action in streptozotocin-diabetic rats.
    Picarel-Blanchot F; Bailbé D; Portha B
    Eur J Pharmacol; 1994 Oct; 264(2):227-32. PubMed ID: 7851488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance in rats with non-insulin-dependent diabetes induced by neonatal (5 days) streptozotocin: evidence for reversal following phlorizin treatment.
    Blondel O; Bailbe D; Portha B
    Metabolism; 1990 Aug; 39(8):787-93. PubMed ID: 2198430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of hypoglycemic action of benfluorex].
    Vigili de Kreutzenberg S; Riccio A; Dorella M; Da Tos V; Del Prato S
    Presse Med; 1992 Sep; 21(28):1340-3. PubMed ID: 1438104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benfluorex decreases insulin resistance and improves lipid profiles in obese type 2 diabetic patients.
    Bianchi R; Bongers V; Bravenboer B; Erkelens DW
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():29S-34S. PubMed ID: 8299486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of benfluorex on serum triacylglycerols and insulin sensitivity in the corpulent rat.
    Russell JC; Graham SE; Dolphin PJ; Brindley DN
    Can J Physiol Pharmacol; 1996 Aug; 74(8):879-86. PubMed ID: 8960376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benfluorex and blood glucose control in non insulin-dependent diabetic patients.
    Cavallo-Perin P; Estivi P; Boine L; Galletti R; Pacini G; Cobelli C; Pagano G
    J Endocrinol Invest; 1991 Feb; 14(2):109-13. PubMed ID: 2061566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of benfluorex in type II diabetic patients on diet regimen alone.
    Velussi M; Monte AD; Cernigoi AM
    J Diabetes Complications; 1996; 10(5):261-6. PubMed ID: 8887014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo hepatic and peripheral insulin sensitivity in rats with non-insulin-dependent diabetes induced by streptozocin. Assessment with the insulin-glucose clamp technique.
    Kergoat M; Portha B
    Diabetes; 1985 Nov; 34(11):1120-6. PubMed ID: 3899811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
    Portha B; Serradas P
    Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
    Serradas P; Bailbé D; Portha B
    Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal B-cell function in rats with non-insulin-dependent diabetes induced by neonatal streptozotocin: effect of in vivo insulin, phlorizin, or vanadate treatments.
    Serradas P; Bailbé D; Blondel O; Portha B
    Pancreas; 1991 Jan; 6(1):54-62. PubMed ID: 1994380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired insulin action but normal insulin receptor activity in diabetic rat liver: effect of vanadate.
    Blondel O; Simon J; Chevalier B; Portha B
    Am J Physiol; 1990 Mar; 258(3 Pt 1):E459-67. PubMed ID: 2180315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in glucose tolerance of insulin resistant rats after chronic or acute administration of benfluorex.
    Lacour F; Espinal J; Arnaud O; Duhault J
    Life Sci; 1993; 53(20):1525-9. PubMed ID: 8412519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in hyperglycemia by mild food restriction in streptozotocin induced diabetic rats improves insulin sensitivity.
    Cameron-Smith D; Collier GR; O'Dea K
    Horm Metab Res; 1994 Jul; 26(7):316-21. PubMed ID: 7959606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats.
    Burcelin R; Eddouks M; Maury J; Kande J; Assan R; Girard J
    Diabetologia; 1995 Mar; 38(3):283-90. PubMed ID: 7758874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiatherogenic effects of long-term benfluorex treatment in male insulin resistant JCR:LA-cp rats.
    Russell JC; Graham SE; Dolphin PJ; Amy RM; Wood GO; Brindley DN
    Atherosclerosis; 1997 Jul; 132(2):187-97. PubMed ID: 9242964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effect of benfluorex on glucose metabolism.
    Bailey CJ; Page T; Day C; Thornburn CC
    Biochem Pharmacol; 1992 Jul; 44(2):379-82. PubMed ID: 1642649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndromes of insulin resistance in the rat. Inducement by diet and amelioration with benfluorex.
    Storlien LH; Oakes ND; Pan DA; Kusunoki M; Jenkins AB
    Diabetes; 1993 Mar; 42(3):457-62. PubMed ID: 8432416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.